Discovery of AZD8931, an Equipotent, Reversible Inhibitor of Signaling by EGFR, HER2, and HER3 Receptors.
ACS Med Chem Lett
; 4(8): 742-6, 2013 Aug 08.
Article
in En
| MEDLINE
| ID: mdl-24900741
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
ACS Med Chem Lett
Year:
2013
Document type:
Article
Affiliation country:
Francia
Country of publication:
Estados Unidos